Prevalence of metabolic syndrome and its components in obese children and adolescents;Prevalencia del síndrome metabólico y sus componentes en niños y adolescentes con obesidad

Anales de Pediatria

Volumn 67, Issue 4, 2007, Pages 352-361

  Tapia Ceballos, L ^a   Lopez Siguero J P ^b   Jurado Ortiz, A ^b  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance; Insulin resistance; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY;

EID: 35449001985     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13110608     Document Type: Article

References (55)

1. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Genève: World Health Organization; 1999.
3. Executive Summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97..
4. Einhorn D, Reaven G, Cobin R, Ford E, Gnada OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
5. Balkau B, Charles M. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
6. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the third National and Nutrition Examination Survey. JAMA. 2002;287:356-9.
7. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey 1988-1994. Arch Pediatr Adolesc Med. 2003;157: 821-7.
8. Chi C, Wang Y, Wilson D, Robinson T. Definition of metabolic syndrome in preadolescent girls. J Pediatr. 2006;148:788-92.
9. López Siguero JP, Fernández García JM, Luna del Castillo JD, Moreno Molina JA. Peso e índice de masa corporal en la población andaluza. Estudio de Crecimiento Andaluz 2005. An Pediatr. 2006;64 Supl 2:121.
10. Marshall W, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
11. Marshall W, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1969;45:12-23.
12. Matthews D, Hosker J, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
13. Katz A, Nambi S, Mather K, Baron AD, Follman DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assesing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
14. Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-97.
15. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28 Suppl 1:S37-S42.
16. Grupo Colaborativo Español para el estudio de factores de riesgo cardiovascular en la infancia y adolescencia. Factores de riesgo cardiovascular en la infancia y adolescencia en España. An Esp Pediatr. 1995;43:11-7.
17. Curvas de Referencia para la Tipificación Ponderal. Dossier de consenso.Grupo colaborativo AEP-SENC-SEEDO. 2002.
18. Cruz M, Weigensberg M, Huang T, Ball G, Shaibi G, Goran M. The metabolic syndrome in overweight Hispanic youth and the role on insulin sensitivity. Clin Endocrinol Metab. 2004;89: 108-13.
19. de Ferranti S, Gauvreau K, Ludwig D, Neufeld E, Newburger J, Rifai N. Prevalence of the Metabolic Syndrome in American Adolescents. Findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-97.
20. Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N Engl J Med. 2004;350:2362-74.
21. Yoshinaga M, Tanaka S, Shimago A, Sameshima K, Nishi J, Nomura Y. Metabolic Syndrome in Overweight and Obese Japanese Children. Obes Res. 2005;13:1135-40.
22. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic syndrome in Turkish children and adolescents. Metabolism Clinical and Experimental. 2006;55:1002-6.
23. Viner R, Segal T, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10-4.
24. Atabek M, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolesecents. Diab Res Clin Pract. 2006;72:315-21.
25. Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A, et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. International J Obesity. 2006;30:627-33.
26. Goodman E, Daniels S, Morrison J, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445-1.
27. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000; 159:91-4.
28. Bao W, Srinivasan S, Wattigney W, Berenson G. Persistence of multiple cardiovascular risk related to syndrome X from childhood to young adulthood. Arch Intern Med. 1994;154:1842-7.
29. Raitakari O, Porkka K, Rasanen L, Ronnemaa T, Vikari J. Clustering and six years cluster-tracking of serum total cholesterol, HDL-cholesterol an diastolic blood pressure in children and young adults. The Cardiovascular Risk in Youngs Finns Study. J Clin Epidemiol. 1994;47:1085-93.
30. Katzmarzyk P, Perusse L, Malina R, Bergeron, Despres JP, Bouchard C. Stability of indicators of metabolic syndrome from chilhood and adolescence to young adult: the Quebec Family Study. J Clin Epidemiol. 2001;54:190-5.
31. Dubose K, Stewart E, Charbonneau S, Mayo M, Donnely J. Prevalence of the metabolic syndrome in elementary school children. Acta Paediatrica. 2006;95:1005-11.
32. Cook S, Auinger P, Daniels S. What best predicts medical complications of obesity? BMI, waist circumference or both. Obes Res 2003;11 Suppl:A27-28.
33. Bueno G, Moreno L, Tresaco B, Bueno M, Garagorri JM. Analisis clínico-metabólico de la insulinorresistencia en niños y adolescentes obesos. An Pediatr. 2003;5 Supl 2:177 (P80).
34. Cabrinety N, Pisonero M, Armenteras A, Ajram J. Valoración de la densitometría mineral ósea e insulinorresistencia en adolescentes obesos. An Pediatr. 2004;60 Supl 2:154 (P96).
35. Colino E, Peña L, Saavedra P, Quinteiro S, Dominguez A, Ramos JC. Síndrome de insulinorresistencia en niños obesos. An Pediatría. 2003;58 Supl 2:176 (P78).
36. Yeste D, Betancourth S, Gussinye M, Potau N, Carrascosa A. Intolerancia a la glucosa en niños y adolescentes con obesidad. Med Clin. 2005;125:405-8.
37. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. International Journal of Obesity. 2005;29:571-8.
38. Mazza C, Ozuna B, Krochik A, raujo MB. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents. J Pediatr Endocrinol Metab. 2005;18:491-8.
39. Barja S, Hodgson M, Acosta A, Arteaga A. Intolerancia a la glucosa en niños obesos. Rev Med Chile. 2003;131:419-26.
40. Elcarte R, Villa I, Sada J. Manual práctico para la prevención de las enfermedades cardiovasculares desde la infancia. Sociedad Nestlé A E P A 1991.
41. Vázquez M. Evolución del perfil lipídico y del riesgo aterogénico del niño al anciano. El Estudio Galinut (tesis). Facultad de Medicina Universidad de Santiago de Compostela; 1998.
42. Lambert M, Delvin E, Paradis G, O'Loughlin J, Hamley J, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clinical Chemistry 2004; 50(10):1762-1768.
43. Ford E, Ajani U, Mokdad A. The Metabolic Syndrome and concentrations of C-Reactive Protein among US youth. Diabetes Care. 2005;28:878-81.
44. Conwell L, Trost S, Brown W, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care. 2004;27:314-9.
45. Cutfield W, Jefferies C, Jackson W, Robinson E, Hofman P. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepuberal children. Pediatr Diabetes. 2003;4:115-8.
46. García E, Lafuente I, Talavera J, Ramos J, Jiménez-Uria MR, Rodríguez FJ. Resistencia insulínica en niños obesos y adolescentes obesos. An Pediatr. 2003;58 Supl 2:177 (P79).
47. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M. Homeostatic model assessment (HOMA) index cutt-of values to identify the metabolic syndrome in children. J Physiol Biochem. 2005;61:381-8.
48. Hanson R, Imperatore G, Bennet P, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes. 2002;51:3120-7.
49. Klein B, Klein R, Lee K. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790-4.
50. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention study. Circulation. 2003;108:414-9.
51. Cruz M, Goran M. The Metabolic Syndrome in Children and Adolescents. Current Diabetes Reports. 2004;4:53-62.
52. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833-41.
53. Freedman D, Dietz W, Srinivasan S, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175-82.
54. Katzmarzyk P, Srinivasan S, Chen W, Malina RM, Boucherd C, Berenson GS. Body mass index, waist circumference, and clustering of cardiovascular disease riskfactors in a biracial sample of children and adolescents. Pediatrics. 2004;114: e198-205.
55. Srinivasan S, Bao W, Wattigney W, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors. The Bogalusa Heart Study. Metabolism. 1996;45:235-40.